Pros and Cons of Marijuana in Treatment of Parkinson's Disease
| dc.contributor.author | Patel, Rikinkumar S. | |
| dc.contributor.author | Kamil, Saher | |
| dc.contributor.author | Shah, Mansi R. | |
| dc.contributor.author | Bhimanadham, Narmada Neerja | |
| dc.contributor.author | Imran, Sundus | |
| dc.contributor.department | Neurology, School of Medicine | en_US |
| dc.date.accessioned | 2019-10-22T20:11:57Z | |
| dc.date.available | 2019-10-22T20:11:57Z | |
| dc.date.issued | 2019-06-03 | |
| dc.description.abstract | Parkinson's disease (PD) is the second most common neurodegenerative disorder of adult onset in the United States. It is a debilitating condition and presents with both motor and non-motor symptoms. Current treatment options are scarce and include replacement of dopamine deficiency with levodopa which targets only motor symptoms of the disorder, does not halt its progression, and is associated with side effects of its own, including dyskinesia. With medical marijuana gaining popularity and being legalized in the United States, we examined the pros and cons of marijuana in the treatment of Parkinson's disease. | en_US |
| dc.identifier.citation | Patel, R. S., Kamil, S., Shah, M. R., Bhimanadham, N. N., & Imran, S. (2019). Pros and Cons of Marijuana in Treatment of Parkinson's Disease. Cureus, 11(6), e4813. doi:10.7759/cureus.4813 | en_US |
| dc.identifier.uri | https://hdl.handle.net/1805/21234 | |
| dc.language.iso | en_US | en_US |
| dc.publisher | Cureus | en_US |
| dc.relation.isversionof | 10.7759/cureus.4813 | en_US |
| dc.relation.journal | Cureus | en_US |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
| dc.source | PMC | en_US |
| dc.subject | Medical marijuana | en_US |
| dc.subject | Marijuana | en_US |
| dc.subject | Parkinson disease | en_US |
| dc.subject | Parkinson | en_US |
| dc.title | Pros and Cons of Marijuana in Treatment of Parkinson's Disease | en_US |
| dc.type | Article | en_US |